Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPATA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RICTOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCART1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLRN1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on